Join the 'Copaxone' group to help and get support from people like you. How it works
Copaxone Blog
| Tweet |
Common Asthma Drug Could Speed MS Treatment
Posted 13 Sep 2010 by Drugs.com
MONDAY, Sept. 13 – A common asthma drug might accelerate the benefits of treatment for multiple sclerosis when combined with standard medicine, new research suggests. The authors of this small and preliminary study showed that albuterol, prescribed for a variety of respiratory illnesses, enhances the effects of glatiramer acetate, a drug already prescribed for MS patients. Because albuterol is known to reduce a substance in the body connected to the onset of MS, doctors at Harvard looked at using the drug as an add-on treatment. Study author Dr. Samia J. Khoury said the study was designed to see if the drug helped reduce symptoms of the inflammatory disease. "Albuterol causes the [immune system] cells to change the type of interleukin they produce to one that is beneficial in MS," said Khoury, a professor of neurology at Harvard Medical School and Brigham and Women's Hospital in ... Read more
Related support groups: Multiple Sclerosis, Albuterol, Copaxone, Ventolin, ProAir HFA, Proventil, Ventolin HFA, Proventil HFA, Glatiramer, Volmax, Respirol, Airet, Vospire ER, AccuNeb